Evidencing Quality Statement Assurance Through Medicines Governance
Medicines governance is a high-risk area of CQC assurance because errors can directly affect people’s safety, wellbeing and confidence in care. Under the CQC quality statements for adult social care, providers must evidence that medicines support is safe, consistent and properly overseen.
Strong medicines oversight contributes to CQC evidence and assurance because it links MAR records, competency checks, incident learning and action tracking. The CQC compliance knowledge hub for care providers supports services to organise this evidence clearly.
Why this matters
Medicines issues are rarely just recording problems. They often reveal wider risks around staff competence, communication, oversight, pharmacy liaison or unclear care plans.
Commissioners and inspectors expect providers to show that medicines systems are actively checked. Evidence should show prevention, prompt response and learning when issues arise.
A practical framework for medicines assurance
Medicines governance should include MAR audits, competency checks, incident reviews, medicines risk assessments, staff briefings and provider oversight.
The strongest evidence shows how medicines risks are identified, corrected and reviewed for impact. It should also show whether people experience safe and reliable support.
Operational Example 1: MAR Audit Follow-Up
Step 1: The medicines lead completes a MAR audit, checks signatures, omissions and refusal entries, and records findings in the medicines audit tool.
Step 2: The registered manager reviews audit findings, identifies repeated recording gaps and records required actions in the medicines governance tracker.
Step 3: The team leader briefs staff on correct MAR completion, records the guidance in the staff communication log and confirms who needs support.
Step 4: The medicines lead completes a focused re-audit, checks whether errors have reduced and records results in the audit review file.
Step 5: The registered manager reviews re-audit evidence, confirms whether action can close and records the decision in governance minutes.
What can go wrong is that MAR gaps are corrected individually without addressing the pattern. Early warning signs include repeated omissions, unclear refusal codes or unsigned entries. Escalation involves staff coaching and competency review. Consistency is maintained through repeat MAR sampling and clear closure evidence.
Governance: MAR audits, governance trackers, communication logs and re-audit files are reviewed monthly by the registered manager. Action is triggered by repeated recording gaps, unclear refusals, failed re-audits or weak staff understanding.
Evidence & Outcomes: The baseline issue was repeated MAR recording errors. Measurable improvement included fewer omissions and clearer refusal evidence. Evidence sources include care records, audits, feedback and staff practice observations.
Operational Example 2: Competency After a Medicines Incident
Step 1: The senior staff member records the medicines incident, including immediate action and clinical advice, in the incident record and medicines log.
Step 2: The medicines lead reviews the staff member’s recent competency record, checks whether practice gaps are present and records findings in the competency file.
Step 3: The registered manager agrees temporary controls, records any task restrictions and updates the rota deployment note.
Step 4: The medicines lead completes observed reassessment, records the staff member’s practice and confirms whether competence is restored.
Step 5: The quality lead reviews later medicines audits, checks whether incident risk reduced and records findings in the provider oversight report.
What can go wrong is that staff return to medicines tasks without reassessment after an error. Early warning signs include uncertainty, repeated prompts or inconsistent checking. Escalation involves temporary restriction and formal reassessment. Consistency is maintained through competency-linked incident review.
Governance: Incident records, medicines logs, competency files and rota controls are reviewed monthly by the quality lead. Action is triggered by repeated incidents, failed reassessment, unclear restrictions or audit evidence of ongoing risk.
Evidence & Outcomes: The baseline issue was weak evidence of reassessment after medicines incidents. Measurable improvement included clearer competency decisions and reduced repeat errors. Evidence includes care records, audits, feedback and staff practice checks.
Operational Example 3: Managing Medicines Changes After Hospital Discharge
Step 1: The care coordinator receives discharge information, checks medicines changes and records the update in the health communication record.
Step 2: The registered manager compares the discharge summary with current MAR arrangements, records discrepancies and contacts pharmacy or clinical professionals for clarification.
Step 3: The medicines lead updates staff instructions, records the change in the handover log and confirms what monitoring is required.
Step 4: Support staff follow the updated medicines guidance, record support given and document any side effects or concerns in daily notes.
Step 5: The registered manager reviews records after the first week, confirms whether the change is safely embedded and records assurance in the governance tracker.
What can go wrong is that discharge changes are received but not fully translated into care delivery. Early warning signs include mismatched records, staff uncertainty or delayed pharmacy clarification. Escalation involves urgent clinical confirmation and manager oversight. Consistency is maintained through discharge medicines checks.
Governance: Discharge records, MAR arrangements, handover logs and daily notes are reviewed after each medicines change by the registered manager. Action is triggered by discrepancies, unclear instructions, side effects, missing monitoring or delayed clarification.
Evidence & Outcomes: The baseline issue was inconsistent handling of medicines changes after discharge. Measurable improvement included faster clarification and safer staff instructions. Evidence sources include care records, audits, feedback and staff practice observations.
Commissioner expectation
Commissioners expect medicines governance to demonstrate safe systems, competent staff and prompt action when risks arise. They want evidence that medicines support remains reliable across shifts, staff teams and service locations.
They also expect learning from incidents and audits. Medicines records should show how errors are prevented, reviewed and reduced through accountable governance.
Regulator / Inspector expectation
Inspectors expect medicines evidence to be current, accurate and connected to practice. They may review MAR charts, incident logs, competency records, care plans and staff explanations.
Strong evidence shows audit, action, reassessment and follow-up. Weak evidence appears when errors are corrected but causes, staff competence and wider risk are not reviewed.
Conclusion
Evidencing quality statement assurance through medicines governance requires providers to show that medicines support is safe, monitored and improved. Medicines evidence must go beyond completed MAR charts.
Governance provides the structure for this assurance. MAR audits, incident records, competency files, discharge checks and action trackers help leaders understand whether medicines systems are reliable.
Outcomes are evidenced through care records, audits, feedback and staff practice. These sources confirm whether medicines governance improves safety, accuracy, confidence and continuity.
Consistency is maintained through regular audit, reassessment after incidents, clear handover and provider oversight. When embedded properly, medicines governance provides strong CQC evidence of safe and well-led care.